E.S. Barr & Co’s Merck MRK Stock Holding History

E.S. Barr & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$546K	Sell	4,536 -5,050	-53%	-$583K	0.03%	70
2025 Q4	$1.01M	Buy	9,586 +5,523	+136%	+$518K	0.05%	54
2025 Q3	$341K	Sell	4,063 -1,101	-21%	-$90.7K	0.02%	90
2025 Q2	$409K	Sell	5,164 -1,617	-24%	-$129K	0.02%	79
2025 Q1	$609K	Sell	6,781 -1,402	-17%	-$131K	0.04%	64
2024 Q4	$814K	Buy	8,183 +1,600	+24%	+$165K	0.05%	58
2024 Q3	$748K	Buy	6,583 +349	+6%	+$41.5K	0.05%	60
2024 Q2	$772K	Sell	6,234 -416	-6%	-$53.6K	0.05%	57
2024 Q1	$877K	Hold	6,650	–	–	0.06%	55
2023 Q4	$725K	Buy	6,650 +1,601	+32%	+$166K	0.05%	58
2023 Q3	$520K	Sell	5,049 -113	-2%	-$12.2K	0.04%	61
2023 Q2	$596K	Buy	5,162 +500	+11%	+$56.8K	0.04%	59
2023 Q1	$496K	Sell	4,662 -250	-5%	-$27K	0.04%	60
2022 Q4	$545K	Hold	4,912	–	–	0.05%	62
2022 Q3	$423K	Sell	4,912 -300	-6%	-$26.8K	0.04%	68
2022 Q2	$475K	Sell	5,212 -463	-8%	-$41K	0.04%	69
2022 Q1	$466K	Sell	5,675 -900	-14%	-$71K	0.03%	75
2021 Q4	$504K	Hold	6,575	–	–	0.03%	73
2021 Q3	$494K	Sell	6,575 -296	-4%	-$22.5K	0.04%	70
2021 Q2	$534K	Buy	6,871 +1,428	+26%	+$106K	0.04%	67
2021 Q1	$400K	Hold	5,443	–	–	0.03%	68
2020 Q4	$425K	Hold	5,443	–	–	0.04%	62
2020 Q3	$431K	Hold	5,443	–	–	0.04%	58
2020 Q2	$402K	Hold	5,443	–	–	0.04%	59
2020 Q1	$400K	Hold	5,443	–	–	0.05%	59
2019 Q4	$472K	Hold	5,443	–	–	0.05%	63
2019 Q3	$437K	Hold	5,443	–	–	0.04%	63
2019 Q2	$436K	Sell	5,443 -158	-3%	-$12.1K	0.04%	64
2019 Q1	$444K	Sell	5,601 -416	-7%	-$31.1K	0.05%	63
2018 Q4	$439K	Sell	6,017 -437	-7%	-$30.8K	0.05%	64
2018 Q3	$437K	Buy	6,454 +27	+0.4%	+$1.72K	0.04%	69
2018 Q2	$372K	Hold	6,427	–	–	0.04%	75
2018 Q1	$334K	Sell	6,427 -210	-3%	-$11.3K	0.04%	73
2017 Q4	$356K	Buy	6,637 +107	+2%	+$5.93K	0.04%	74
2017 Q3	$399K	Hold	6,530	–	–	0.04%	70
2017 Q2	$399K	Buy	6,530 +574	+10%	+$34.9K	0.04%	66
2017 Q1	$361K	Sell	5,956 -367	-6%	-$22.3K	0.04%	67
2016 Q4	$355K	Hold	6,323	–	–	0.04%	66
2016 Q3	$377K	Buy	6,323 +158	+3%	+$9.24K	0.05%	64
2016 Q2	$339K	Hold	6,165	–	–	0.04%	67
2016 Q1	$311K	Sell	6,165 -552	-8%	-$27K	0.04%	69
2015 Q4	$339K	Sell	6,717 -52	-0.8%	-$2.62K	0.04%	69
2015 Q3	$319K	Buy	6,769 +120	+2%	+$6.38K	0.04%	69
2015 Q2	$361K	Hold	6,649	–	–	0.04%	65
2015 Q1	$365K	Sell	6,649 -244	-4%	-$13.8K	0.04%	64
2014 Q4	$374K	Sell	6,893 -509	-7%	-$28.4K	0.04%	64
2014 Q3	$419K	Buy	7,402 +195	+3%	+$10.9K	0.05%	65
2014 Q2	$398K	Hold	7,207	–	–	0.05%	63
2014 Q1	$390K	Sell	7,207 -807	-10%	-$41.8K	0.05%	63
2013 Q4	$383K	Buy	8,014 +1,321	+20%	+$60.4K	0.05%	67
2013 Q3	$304K	Buy	6,693 +222	+3%	+$10.1K	0.04%	66
2013 Q2	$287K	Buy	+6,471	New	+$289K	0.04%	65

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

E.S. Barr & Co's MRK Position: Q1 2026 in Review

E.S. Barr & Co reduced its Merck (MRK) stake by 53% in Q1 2026, selling an estimated $583K and leaving 4,536 shares worth $546K. The position accounts for 0.03% of the portfolio, ranked #70.

E.S. Barr & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

E.S. Barr & Co held 4,536 shares of Merck worth $546K as of Q1 2026.
E.S. Barr & Co sold 5,050 Merck shares in Q1 2026, an estimated $583K.
Merck made up 0.03% of E.S. Barr & Co's portfolio in Q1 2026, its #70 holding.
E.S. Barr & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
E.S. Barr & Co's Merck position peaked at $1.01M in Q4 2025.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on E.S. Barr & Co's 13F filing for Q1 2026, filed 13 May 2026.